These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 19272804)

  • 1. The oncogenic effects of constitutive Stat3 signaling in salivary gland cancer cells are mediated by survivin and modulated by the NSAID sulindac.
    Nikitakis NG; Scheper MA; Papanikolaou VS; Sauk JJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jun; 107(6):826-36. PubMed ID: 19272804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer.
    Scheper MA; Nikitakis NG; Sauk JJ
    Int J Oral Maxillofac Surg; 2007 Jul; 36(7):632-9. PubMed ID: 17566705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulindac induces apoptosis and inhibits tumor growth in vivo in head and neck squamous cell carcinoma.
    Scheper MA; Nikitakis NG; Chaisuparat R; Montaner S; Sauk JJ
    Neoplasia; 2007 Mar; 9(3):192-9. PubMed ID: 17401459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-independent antineoplastic effects of sulindac in oral cancer are mediated by survivin down-regulation.
    Scheper MA; Sauk JJ; Nikitakis NG
    Anticancer Res; 2006; 26(6B):4103-13. PubMed ID: 17201121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nonsteroidal anti-inflammatory drug sulindac causes down-regulation of signal transducer and activator of transcription 3 in human oral squamous cell carcinoma cells.
    Nikitakis NG; Hamburger AW; Sauk JJ
    Cancer Res; 2002 Feb; 62(4):1004-7. PubMed ID: 11861373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARgamma-mediated antineoplastic effect of NSAID sulindac on human oral squamous carcinoma cells.
    Nikitakis NG; Hebert C; Lopes MA; Reynolds MA; Sauk JJ
    Int J Cancer; 2002 Apr; 98(6):817-23. PubMed ID: 11948457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of the oncogenic molecules active Stat3 and survivin in benign and malignant salivary gland tumors.
    Nikitakis NG; Scheper MA; Papanikolaou VS; Sklavounou A; Sauk JJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jun; 107(6):837-43. PubMed ID: 19272817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
    Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
    Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines.
    Gu L; Chiang KY; Zhu N; Findley HW; Zhou M
    Exp Hematol; 2007 Jun; 35(6):957-66. PubMed ID: 17533050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Apoptosis resistance induced by leptin and its mechanism in breast cancer cells].
    Zhao TS; Jiang HP; Wang XC; Ren H; Hao JH
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):651-4. PubMed ID: 20021858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
    Gritsko T; Williams A; Turkson J; Kaneko S; Bowman T; Huang M; Nam S; Eweis I; Diaz N; Sullivan D; Yoder S; Enkemann S; Eschrich S; Lee JH; Beam CA; Cheng J; Minton S; Muro-Cacho CA; Jove R
    Clin Cancer Res; 2006 Jan; 12(1):11-9. PubMed ID: 16397018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a JAK inhibitor, AG490, on proliferation and apoptosis of human nasopharyngeal carcinoma cell line CNE-2Z.
    Wu MH; Chen XY; Cai KR
    Ai Zheng; 2009 Jan; 28(1):24-8. PubMed ID: 19448411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stat3 activation in human endometrial and cervical cancers.
    Chen CL; Hsieh FC; Lieblein JC; Brown J; Chan C; Wallace JA; Cheng G; Hall BM; Lin J
    Br J Cancer; 2007 Feb; 96(4):591-9. PubMed ID: 17311011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug resistance-associated protein 7 expression is involved in cross-resistance to docetaxel in salivary gland adenocarcinoma cell lines.
    Naramoto H; Uematsu T; Uchihashi T; Doto R; Matsuura T; Usui Y; Uematsu S; Li X; Takahashi M; Yamaoka M; Furusawa K
    Int J Oncol; 2007 Feb; 30(2):393-401. PubMed ID: 17203221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo.
    Pyrko P; Soriano N; Kardosh A; Liu YT; Uddin J; Petasis NA; Hofman FM; Chen CS; Chen TC; Schönthal AH
    Mol Cancer; 2006 May; 5():19. PubMed ID: 16707021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of STAT3 activation and expression in canine and human osteosarcoma.
    Fossey SL; Liao AT; McCleese JK; Bear MD; Lin J; Li PK; Kisseberth WC; London CA
    BMC Cancer; 2009 Mar; 9():81. PubMed ID: 19284568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells.
    Nam K; Son SH; Oh S; Jeon D; Kim H; Noh DY; Kim S; Shin I
    Oncotarget; 2017 May; 8(22):35804-35823. PubMed ID: 28415760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulindac modulates secreted protein expression from LIM1215 colon carcinoma cells prior to apoptosis.
    Greening DW; Ji H; Kapp EA; Simpson RJ
    Biochim Biophys Acta; 2013 Nov; 1834(11):2293-307. PubMed ID: 23899461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin.
    Jin HO; Yoon SI; Seo SK; Lee HC; Woo SH; Yoo DH; Lee SJ; Choe TB; An S; Kwon TJ; Kim JI; Park MJ; Hong SI; Park IC; Rhee CH
    Biochem Pharmacol; 2006 Nov; 72(10):1228-36. PubMed ID: 16950207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin inhibits constitutive STAT3 phosphorylation in human pancreatic cancer cell lines and downregulation of survivin/BIRC5 gene expression.
    Glienke W; Maute L; Wicht J; Bergmann L
    Cancer Invest; 2010 Feb; 28(2):166-71. PubMed ID: 20121547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.